Biomedical Seminars Calendar –

School of Medicine Home > Education > Biomedical Seminars

Among children with B-cell progenitor acute lymphoblastic leukemia (ALL), the most common kind of childhood cancer, 15% of children will relapse after initially responding to standard therapies, and 50% of children who relapse will die, making relapsed ALL the second-leading cause of cancer-related death in children. Even with the emergence of novel immunotherapies, including chimeric antigen receptor (CAR) T-cells, at least 40% of children with ALL who initially respond to these novel therapies will still go on to relapse. In this talk, Dr. Kara Davis will discuss the use of a single-cell mass cytometry, or CyTOF, to identify cells associated with relapse from diagnostic patient samples.

Department:  Stanford Maternal and Child Health Research Institute

Contact: Roxanna Van Norman | 6504985444 | roxannav@stanford.edu

Presenter(s):

• Kara Davis, DO Assistant Professor, Pediatrics (Hematology and Oncology)

        Course Website

© 2019 Stanford University School of Medicine   |  Terms of Use   |   Maps   |   Contacts   |   Jobs   |   Lane Medical Library